SPLICING OF MAMU AG MRNA SUGGESTS EXISTENCE OF SOLUBLE MHC CLASS I MOLECULE

MAMU AG mRNA 的剪接表明可溶性 MHC I 类分子的存在

基本信息

  • 批准号:
    6116422
  • 负责人:
  • 金额:
    $ 6.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-05-01 至 2000-04-30
  • 项目状态:
    已结题

项目摘要

OBJECTIVE To determine whether mRNAs are expressed in the rhesus placenta which could encode a soluble MHC class I molecule. RESULTS An unusual feature of both the human placental MHC class I molecule HLA-G and the rhesus molecule Mamu-AG is expression of multiple protein isoforms and splice variants. Splice variants also exist for HLA-G which encode a soluble protein but the presence of a mRNA encoding a soluble rhesus MHC class I molecule has not previously been detected. We cloned a fragment of the Mamu-AG gene from rhesus monkey genomic DNA to define the sequences of intron 4 and 5 and noted that the sequence of intron 4 was highly homologous to that of HLA-G (88% identical), which is similar to exon 4 homology with HLA-A sequences (~91%), but higher than that for intron 5, suggesting that evolutionary drift of intron 4 has been restrained and implying selection for functionally important sequences. We then conducted RT-PCR analyses with placental mRNA using an upstream primer specific for Mamu-AG exon 4, and a downstream primer which would amplify through the 3U-untranslated region and allow diagnostic identification of Mamu-AG transcripts via the premature stop codon homologous to HLA-G. RT-PCR products were amplified from placental RNA, cloned and sequenced. A stop codon (TAG) is present in the exact codon location of the TAA stop codon in the soluble HLA-G reading frame of intron 4. The predicted amino acid sequences of the carboxy-terminal end of the 4th exon and the intron 4 peptides indicate identity with the human sequence at 16/21 residues, and conservative substitutions (e.g., G to S) at the other 5 residues. Further studies cloned and defined the sequences of the other introns of Mamu-AG. FUTURE DIRECTIONS These results suggest that the rhesus monkey will be a model for addressing the physiology of soluble Mamu-AG. We will evaluate 1) the expression of soluble mRNA in the fetal membranes, 2) whether antibodies against soluble HLA-G recognize the rhesus molecule, and 3) rhesus amniotic fluid and fetal serum for the presence of soluble MHC class I molecules. KEY WORDS maternal-fetal immune tolerance, placenta, amniotic fluid, splice variant FUNDING NIH HD 26458, HD34216
目的研究恒河猴体内是否存在mRNAs表达。 胎盘可以编码一种可溶性的MHC-I类分子。结果 人类胎盘MHC I类分子的一个不同寻常的特征 人类白细胞抗原-G和恒河猴分子MAMU-AG是多重表达的 蛋白质异构体和剪接变体。拼接变体也存在于 人类白细胞抗原G编码一种可溶性蛋白,但存在一种 编码可溶性恒河猴MHC I类分子以前从未被 检测到。我们克隆了恒河猴MAMU-AG基因的一个片段 基因组DNA来定义内含子4和5的序列,并注意到 内含子4的序列与人类白细胞抗原G基因高度同源(88% 相同),与外显子4相似,与人类白细胞抗原-A序列同源 (~91%),但高于内含子5,表明 内含子4的进化漂移受到抑制并暗示 功能重要序列的选择。然后我们进行了 用上游特异性引物RT-PCR分析胎盘组织中的mRNA 针对MAMU-AG外显子4,以及可扩增出 通过3U-非翻译区并允许诊断识别 通过与MAMU-AG同源的提前终止密码子 人类白细胞抗原G。从胎盘RNA中扩增RT-PCR产物,克隆和 已排序。终止密码子(标签)存在于准确的密码子位置 TAA终止密码子位于内含子4可溶的人类白细胞抗原-G阅读框中。 预测的氨基酸序列的羧基末端 第4外显子和第4内含子多肽表明与人类相同 16/21残基的序列和保守的替换(例如,G到 S)在其他5个残基上。进一步的研究克隆和定义了 MAMU-AG其他内含子的序列。这些是未来的方向 结果表明,恒河猴将是解决 可溶性MAMU-AG的生理特性。我们将对1)表达式求值 胎膜中可溶性mRNA的表达,2)抗体是否针对 可溶性人类白细胞抗原-G识别恒河猴分子;3)恒河猴羊水 体液和胎儿血清中可溶性MHC-I类的检测 分子。关键词母胎免疫耐受、胎盘、 羊水,剪接变异资助,美国国立卫生研究院HD 26458,HD34216

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THADDEUS G GOLOS其他文献

THADDEUS G GOLOS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THADDEUS G GOLOS', 18)}}的其他基金

Targeted Delivery of Liposomes to the Primate Maternal-Fetal Interface
将脂质体靶向递送至灵长类母胎界面
  • 批准号:
    9979328
  • 财政年份:
    2020
  • 资助金额:
    $ 6.42万
  • 项目类别:
Magnetic resonance imaging of the antecedents of fetal growth restriction at the primate maternal-fetal interface
灵长类母胎界面胎儿生长受限前因的磁共振成像
  • 批准号:
    10237390
  • 财政年份:
    2020
  • 资助金额:
    $ 6.42万
  • 项目类别:
Magnetic resonance imaging of the antecedents of fetal growth restriction at the primate maternal-fetal interface
灵长类母胎界面胎儿生长受限前因的磁共振成像
  • 批准号:
    10404011
  • 财政年份:
    2020
  • 资助金额:
    $ 6.42万
  • 项目类别:
Magnetic resonance imaging of the antecedents of fetal growth restriction at the primate maternal-fetal interface
灵长类母胎界面胎儿生长受限前因的磁共振成像
  • 批准号:
    10074849
  • 财政年份:
    2020
  • 资助金额:
    $ 6.42万
  • 项目类别:
Project 1: Impact of sustained ZIKV viremia in pregnancy
项目 1:妊娠期持续 ZIKV 病毒血症的影响
  • 批准号:
    10220702
  • 财政年份:
    2018
  • 资助金额:
    $ 6.42万
  • 项目类别:
Pathways of vertical Zika virus transmission in nonhuman primate pregnancy
非人灵长类动物怀孕期间寨卡病毒垂直传播的途径
  • 批准号:
    9894729
  • 财政年份:
    2018
  • 资助金额:
    $ 6.42万
  • 项目类别:
Nonhuman Primate Model to Assess Fetal Zika Virus Infection Complications
用于评估胎儿寨卡病毒感染并发症的非人类灵长类动物模型
  • 批准号:
    9262695
  • 财政年份:
    2017
  • 资助金额:
    $ 6.42万
  • 项目类别:
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
CCR5突变猴模型促进新型干细胞艾滋病疗法的开发
  • 批准号:
    9264608
  • 财政年份:
    2016
  • 资助金额:
    $ 6.42万
  • 项目类别:
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
CCR5突变猴模型促进新型干细胞艾滋病疗法的开发
  • 批准号:
    9490509
  • 财政年份:
    2016
  • 资助金额:
    $ 6.42万
  • 项目类别:
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
CCR5突变猴模型促进新型干细胞艾滋病疗法的开发
  • 批准号:
    9140295
  • 财政年份:
    2016
  • 资助金额:
    $ 6.42万
  • 项目类别:

相似海外基金

Pioneering reproductive biotechnology innovations for equine breeding
开创马匹育种生殖生物技术创新
  • 批准号:
    LP230100156
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Linkage Projects
Industrial Biotechnology Innovation Cluster
产业生物技术创新集群
  • 批准号:
    EP/Y024168/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Research Grant
Environmental Biotechnology Innovation Centre
环境生物技术创新中心
  • 批准号:
    BB/Y008332/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Research Grant
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
  • 批准号:
    2330663
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Standard Grant
Conference: Translating Molecular Science Innovations into Biotechnology Solutions
会议:将分子科学创新转化为生物技术解决方案
  • 批准号:
    2419731
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Standard Grant
Shear Innovation: Valorising wool waste using biotechnology to enhance horticultural peat-free growing media
剪切创新:利用生物技术提高羊毛废料的价值,以增强园艺无泥炭生长介质
  • 批准号:
    10106787
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Launchpad
NSF Convergence Accelerator Track M: Biofilm-based Corrosion Control using 3D Printed Biotechnology
NSF 融合加速器轨道 M:使用 3D 打印生物技术进行基于生物膜的腐蚀控制
  • 批准号:
    2344389
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Standard Grant
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
  • 批准号:
    2421022
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Standard Grant
Engineering Biology Hub for environmental processing and recovery of metals; from contaminated land to industrial biotechnology in a circular economy
用于环境处理和金属回收的工程生物中心;
  • 批准号:
    BB/Y008456/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Research Grant
Development of magnetic force biotechnology to facilitate neural regeneration
开发磁力生物技术促进神经再生
  • 批准号:
    EP/X014126/1
  • 财政年份:
    2023
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了